rs35523808
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_004370.6(COL12A1):c.6479A>T(p.Glu2160Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0437 in 1,607,394 control chromosomes in the GnomAD database, including 1,864 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.034 ( 135 hom., cov: 32)
Exomes 𝑓: 0.045 ( 1729 hom. )
Consequence
COL12A1
NM_004370.6 missense
NM_004370.6 missense
Scores
4
5
9
Clinical Significance
Conservation
PhyloP100: 7.36
Publications
18 publications found
Genes affected
COL12A1 (HGNC:2188): (collagen type XII alpha 1 chain) This gene encodes the alpha chain of type XII collagen, a member of the FACIT (fibril-associated collagens with interrupted triple helices) collagen family. Type XII collagen is a homotrimer found in association with type I collagen, an association that is thought to modify the interactions between collagen I fibrils and the surrounding matrix. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
COL12A1 Gene-Disease associations (from GenCC):
- Bethlem myopathy 2Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet
- Bethlem myopathy 2Inheritance: AD Classification: STRONG, LIMITED Submitted by: Ambry Genetics, Illumina, Genomics England PanelApp
- Ullrich congenital muscular dystrophy 2Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- Bethlem myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Ullrich congenital muscular dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.003599733).
BP6
Variant 6-75125255-T-A is Benign according to our data. Variant chr6-75125255-T-A is described in ClinVar as Benign. ClinVar VariationId is 259344.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0523 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| COL12A1 | ENST00000322507.13 | c.6479A>T | p.Glu2160Val | missense_variant | Exon 40 of 66 | 1 | NM_004370.6 | ENSP00000325146.8 | ||
| COL12A1 | ENST00000345356.10 | c.2987A>T | p.Glu996Val | missense_variant | Exon 25 of 51 | 1 | ENSP00000305147.9 | |||
| COL12A1 | ENST00000483888.6 | c.6479A>T | p.Glu2160Val | missense_variant | Exon 40 of 65 | 5 | ENSP00000421216.1 | |||
| COL12A1 | ENST00000416123.6 | c.6479A>T | p.Glu2160Val | missense_variant | Exon 39 of 63 | 5 | ENSP00000412864.2 |
Frequencies
GnomAD3 genomes AF: 0.0344 AC: 5235AN: 152082Hom.: 134 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
5235
AN:
152082
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0343 AC: 8376AN: 243970 AF XY: 0.0348 show subpopulations
GnomAD2 exomes
AF:
AC:
8376
AN:
243970
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0446 AC: 64952AN: 1455194Hom.: 1729 Cov.: 31 AF XY: 0.0438 AC XY: 31702AN XY: 723574 show subpopulations
GnomAD4 exome
AF:
AC:
64952
AN:
1455194
Hom.:
Cov.:
31
AF XY:
AC XY:
31702
AN XY:
723574
show subpopulations
African (AFR)
AF:
AC:
234
AN:
33244
American (AMR)
AF:
AC:
896
AN:
43932
Ashkenazi Jewish (ASJ)
AF:
AC:
774
AN:
25900
East Asian (EAS)
AF:
AC:
4
AN:
39446
South Asian (SAS)
AF:
AC:
594
AN:
84734
European-Finnish (FIN)
AF:
AC:
3057
AN:
53282
Middle Eastern (MID)
AF:
AC:
159
AN:
5746
European-Non Finnish (NFE)
AF:
AC:
56868
AN:
1108772
Other (OTH)
AF:
AC:
2366
AN:
60138
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
2774
5548
8321
11095
13869
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2024
4048
6072
8096
10120
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0344 AC: 5233AN: 152200Hom.: 135 Cov.: 32 AF XY: 0.0337 AC XY: 2511AN XY: 74424 show subpopulations
GnomAD4 genome
AF:
AC:
5233
AN:
152200
Hom.:
Cov.:
32
AF XY:
AC XY:
2511
AN XY:
74424
show subpopulations
African (AFR)
AF:
AC:
351
AN:
41538
American (AMR)
AF:
AC:
369
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
AC:
98
AN:
3470
East Asian (EAS)
AF:
AC:
0
AN:
5184
South Asian (SAS)
AF:
AC:
34
AN:
4828
European-Finnish (FIN)
AF:
AC:
608
AN:
10600
Middle Eastern (MID)
AF:
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3651
AN:
67984
Other (OTH)
AF:
AC:
71
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
262
523
785
1046
1308
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
66
132
198
264
330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
183
ALSPAC
AF:
AC:
169
ESP6500AA
AF:
AC:
35
ESP6500EA
AF:
AC:
390
ExAC
AF:
AC:
4037
Asia WGS
AF:
AC:
18
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:3
-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided Benign:1
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Bethlem myopathy 2;C4225314:Ullrich congenital muscular dystrophy 2 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;.;.;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D;D;D;D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;L;.;L;.
PhyloP100
PrimateAI
Uncertain
T
PROVEAN
Uncertain
.;D;D;D;D
REVEL
Benign
Sift
Uncertain
.;D;D;D;D
Sift4G
Pathogenic
D;D;D;D;D
Polyphen
1.0
.;D;D;.;.
Vest4
MPC
1.5
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.